Prevalence and Public-health Significance of HIV Infection and Anaemia among Pregnant Women Attending Antenatal Clinics in South-eastern Nigeria by Uneke, C.J. et al.
Prevalence and Public-health Significance of HIV 
Infection and Anaemia among Pregnant 
Women Attending Antenatal Clinics in 
South-eastern Nigeria
C.J. Uneke1, D.D. Duhlinska2, and E.B. Igbinedion3
1Department of Medical Microbiology/Parasitology, Faculty of Clinical Medicine, Ebonyi State University, Abakaliki, Nigeria, 
2Department of Zoology, Faculty of Natural Sciences, University of Jos, Nigeria, and 3Department of Applied Microbiology, 
Faculty of Applied and Natural Sciences, Ebonyi State University, Abakaliki, Nigeria
ABSTRACT
HIV infection and anaemia are major public-health problems in Africa and are important factors associated 
with an increased risk of adverse pregnancy outcomes. The objective of this study was to determine the 
prevalence of HIV infection and anaemia among pregnant women attending antenatal clinics in south-
eastern Nigeria. To achieve this, a cross-sectional survey was conducted during July 2005–June 2006 using 
standard techniques. Of 815 pregnant women studied, 31 (3.8%, 95% confidence interval [CI] 2.5-5.1) 
were HIV-positive. Maternal age and gestational age were not associated with HIV infection (p>0.05). The 
prevalence of anaemia (Hb   <11.0 g/dL) was 76.9%, and 15 (1.8%, 95% CI 0.9-2.7) had severe anaemia 
(Hb   <7.0 g/dL). A significantly higher prevalence of anaemia was observed among individuals in their 
second pregnancy trimester (p<0.05) and those infected with HIV (p<0.05). Since HIV and anaemia are 
preventable, antenatal care services could serve as a pivotal entry point for simultaneous delivery of inter-
ventions for the prevention and control of HIV infection and anaemia in pregnant women.
Key words: Anaemia; Cross-sectional surveys; HIV; HIV infections; Maternal health; Morbidity; Mortality; 
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INTRODUCTION
Despite the considerable improvement in health-
care-delivery services in many parts of the African 
continent, making motherhood safer, which is an 
urgent priority and one of several child-survival 
strategies applied through antenatal care, conti-
nues to be particularly challenging. Anaemia in 
pregnancy has been described as one of such enor-
mous medical challenges because it is a major 
public-health problem in Africa and is an impor-
tant factor associated with an increased risk of poor 
pregnancy outcomes (1) and maternal morbidity 
and mortality in developing countries (2). In sub-Sa-
haran Africa, a high prevalence (95.4%) of anae-
mia has been reported among pregnant women 
(3), with the mean prevalence of maternal anaemia 
in the subregion estimated to be 61% (4). Anae-
mia even when mild is associated with reduced 
productivity at work (5). During pregnancy, severe 
anaemia may result in circulatory changes that are 
associated with an increased risk of heart failure (6). 
During labour, women with severe anaemia are less 
able to endure even moderate blood loss and, as 
a consequence, are at a higher risk of requiring a 
blood transfusion during delivery (7,8). In addi-
tion, severe anaemia in pregnancy is an important 
direct and indirect cause of maternal death (9,10), 
and for the foetus, severe maternal anaemia may 
result in intrauterine growth retardation, stillbirth, 
and low birthweight (11-13).  
The aetiology of anaemia in pregnancy in sub-
Saharan Africa is complex and multifactorial (7). 
Apart from malaria, other causes of anaemia in 
pregnancy include an iron- and folate-deficient 
diet and infections, such as hookworm, and in-
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creasingly human immunodeficiency virus (HIV) 
(14). It has been suggested that infection with HIV 
during pregnancy may be associated with an in-
creased risk of anaemia-related maternal death in 
developing-country settings due to the increasing 
severity of anaemia or due to the combined effects 
of anaemia and other infections (15). Anaemia also 
has been associated with progression of HIV disease 
(16). Concerning the global HIV epidemic, sub-Sa-
haran Africa remains by far the worst-affected re-
gion with 25.4 million people living with HIV (just 
under two-thirds, i.e. 64% of all people living with 
HIV) (17). The HIV/AIDS epidemic is affecting fe-
males most severely in the subregion, and women 
of reproductive age make up almost 57% of adults 
living with HIV, accounting for up to 80% of HIV-
infected women in the world (17,18), with HIV-
prevalence rates sometimes exceeding 40% among 
pregnant women (19,20).
The HIV/AIDS epidemic intersects with the prob-
lem of maternal mortality in many circumstances 
in sub-Saharan Africa. The extent of the contribu-
tion of HIV/AIDS to maternal mortality is difficult 
to quantify, as the HIV status of pregnant women 
in the subregion is not always known (21). HIV 
impacts on direct (obstetrical) causes of maternal 
mortality by an associated increase in pregnancy-
related complications, such as anaemia, postpar-
tum haemorrhage, and puerperal sepsis (8,21). 
Although anaemia is highly prevalent during 
pregnancy and is common during HIV infection, 
anaemia and iron status have not been well-char-
acterized in HIV-infected pregnant women in most 
parts of sub-Saharan Africa (22). A relationship be-
tween HIV seropositivity and a decreased haemo-
globin (Hb) concentration in pregnancy has been 
suggested, and the inclusion of HIV screening in 
differential diagnosis of anaemia is recommended 
(23). However, the paucity of comprehensive popu-
lation-based data on anaemia and HIV infection in 
pregnancy in Nigeria and other parts of West Af-
rica with a similar setting makes the formulation 
of policies that would transform into effective and 
sustainable  intervention/control  programmes  for 
pregnant women an enormous challenge to health 
policy-makers. 
This present study was, therefore, designed to pro-
vide scientific information on the prevalence of 
anaemia and HIV infection and associated factors 
to maternal anaemia, which can be used for direct-
ing policy development and control-programme 
implementation and also provide a baseline mea-
surement on which the impact of interventions 
can be evaluated. The public-health implications of 
findings as they affect the overall maternal well-be-
ing in this part of the globe are discussed. 
MATERIALS AND METHODS
Study area
This investigation was conducted in two major cit-
ies—Abakaliki, the Ebonyi State capital, and Enugu, 
the Enugu State capital—in south-eastern Nigeria 
during July 2005–June 2006. The study settings are 
separated by a distance of about 100 km and have 
similar socioeconomic, ethnic and religious charac-
teristics, except that Enugu is a much more deve-
loped city than Abakaliki, particularly in terms of 
commerce and industries. Two of the largest hospi-
tals in the cities—Ebonyi State University Teaching 
Hospital (EBSUTH), Abakaliki and Balm of Gilead 
Hospital (BGH), Enugu, which serve as referral cen-
tres for gynaecological services and run the biggest 
antenatal clinics, were used for the study. 
Ethical considerations
Ethical approval for this study was obtained from 
the Faculty of Clinical Medicine (Infectious Diseas-
es Research Division, Department of Medical Mi-
crobiology), Ebonyi State University, Abakaliki, and 
from the ethical committee of the EBSUTH, Abaka-
liki and of the BGH, Enugu. Approval was granted 
subject to patient anonymity being maintained, 
good laboratory practice/quality control being en-
sured, and every finding being treated with utmost 
confidentiality and for the purpose of this research 
only. All work was performed according to the in-
ternational guidelines for human experimentation 
in clinical research (24).
Study population/sampling technique
Pregnant women in their various pregnancy trimes-
ters who visited the antenatal clinics (ANCs) of the 
EBSUTH, Abakaliki, and the BGH, Enugu, within 
the study period, at their first visit to the antenatal 
care clinic since the commencement of pregnancy 
were considered for the study. All the subjects 
were verbally notified prior to sample collection, 
and their informed consent was duly obtained. 
Age of each woman and pregnancy trimester was 
determined by interview. A sample of about four 
mL of blood was obtained by venepuncture from 
each patient for analysis. For the purpose of the re-
search, no personal identifiers (names, ID number, 
address, etc.) were used on the blood sample of 
the participants. Instead, bar-coded numbers 
were used for ensuring anonymity of the donors, Uneke C.J et al. HIV infection and anaemia in pregnancy
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facilitating  laboratory  procedures,  and  minimiz-
ing the chances of errors during the handling of 
the blood specimens. All specimens were analyzed 
within one hour of collection.
Laboratory analysis
Blood samples obtained from the subjects at the 
BGH, Enugu, were analyzed at the laboratory unit 
of the hospital for haemoglobin (Hb) concentration 
using the cyanmethaemoglobin method described 
previously (25); reading was done using a spectro-
photometer (Bayer RA 50). The packed cell volume 
(PCV) was determined for samples obtained from 
subjects at the EBSUTH, Abakaliki, using the hae-
matocrit technique (25), at the Research Laboratory 
of the Department of Medical Microbiology, Ebo-
nyi State University, Abakaliki. The PCV (%) values 
were converted to Hb (g/dL) by applying the con-
stant factor of 0.3 (26). The commercially-available 
HIV Tri Line Test-kits (Biosystem Inc, Austria) were 
first used for screening the serum sample of each 
subject which was separated from blood to detect 
antibodies to HIV-1 and HIV-2. Thereafter, HIV-se-
ropositive samples were confirmed by immunoblot 
analysis using the commercially-available BIORAD 
New Lav Blot-kits (Bio-Rad Novapath Diagnostic 
Group, USA). The instructions of the manufacturer 
were strictly followed to determine the serostatus 
of the samples.
Results of both HIV and haemoglobin tests were 
made available to all the study participants. All the 
pregnant women who were HIV-positive were in-
formed of their HIV status by their physicians and 
were offered counselling and also enrolled into the 
free maternal antiretroviral therapy programme of 
the EBSUTH. Also, all the women after enrollment 
at the antenatal clinics of the two hospitals were 
given chemoprophylaxis, including haematinics, 
to treat anaemia, particularly for those who were 
anaemic.
Statistical analysis
The 95% confidence interval was calculated using 
the standard method. The differences in propor-
tion were evaluated using the chi-square test. The 
statistical significance was achieved if p value was 
<0.05.
RESULTS
In this investigation, a combined total of 815 preg-
nant  women  were  studied,  and  31  (3.8%,  95% 
CI 2.5-5.1) of these women were HIV-positive. A 
higher prevalence of HIV infection was recorded 
at the EBSUTH, Abakaliki, where 21 (5.3%, 95% CI 
3.1-7.5) of 394 individuals screened were infected 
with HIV, while at the BGH, Enugu, 10 (2.3%, 95% 
CI 0.9-3.7) of 421 pregnant women screened had 
HIV infection (Table 1). When maternal age was 
associated with HIV infection, the prevalence de-
creased with increase in age. Although individuals 
in the 20 years and less age-category recorded the 
highest prevalence of HIV infection, the differ-
ence in the trend was not statistically significant 
(χ2=2.23, p>0.05). The association of HIV infection 
with gestational age indicated that the highest in-
fected individuals were more likely to be in their 
third pregnancy trimester. However, there was also 
no statistically significant difference in the trend 
(χ2=1.71, p>0.05) (Table 1).  
Of the 815 women screened, 15 (1.8%, 95% CI 0.9-
2.7) had severe anaemia (Hb <7.0 g/dL). The com-
bined prevalence of anaemia (Hb <11.0 g/dL) was 
76.9%.  A  higher  prevalence  (83.8%)  of  anaemia 
was recorded among the subjects at the EBSUTH, 
Abakaliki, than their counterparts at the BGH, Enu-
gu (70.5%). The prevalence of anaemia decreased 
with age but the difference was not statistically 
significant (χ2=5.06, p>0.05) (Table 2). When ges-
tational age was related with anaemia, individuals 
in their second pregnancy trimester had a signifi-
cantly higher prevalence of anaemia than those in 
their first and third pregnancy trimesters (χ2=9.24, 
p<0.05). The prevalence of anaemia was signifi-
cantly higher among the HIV-positive women than 
those who were HIV-negative (χ2=7.23, p<0.05) 
(Table 2). The mean haemoglobin concentration of 
the HIV-positive women was 8.6 g/dL, while that of 
the HIV-negative women was 10.2 g/dL.  
DISCUSSION
The results of this investigation confirmed the re-
sults of earlier reports from various parts of sub-Sa-
haran Africa which indicated that the prevalence 
of anaemia among pregnant women is unaccept-
ably high in the region (3-7). Although anaemia in 
pregnancy in sub-Saharan Africa has multiple aetio-
logies, in countries with a high prevalence of HIV 
infection, anaemia due to underlying nutritional 
deficiencies may be intensified by parasitic infec-
tions, compromised immunity, and the haemato-
logical consequences of chronic and systemic in-
flammation (14). In this present investigation, up 
to 76.9% of the total number of pregnant women 
studied were anaemic (with Hb <11 g/dL), and HIV 
infection was a major contributor to anaemia seen 
in pregnancy. These findings are consistent with Uneke C.J et al. HIV infection and anaemia in pregnancy
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those of some earlier reports (8,15,16,22). A younger 
age appeared to be a higher risk factor to both HIV 
infection and anaemia but the differences were not 
statistically significant (p>0.05).
The relationship between HIV seropositivity and a 
decreased haemoglobin concentration in pregnan-
cy, which was suggested earlier (23), was confirmed 
in the present study. Our results showed that the 
prevalence of anaemia was significantly higher 
among the HIV-positive women than among the 
HIV-negative women (p<0.05), and a lower mean 
haemoglobin concentration was recorded among 
the HIV-positive women compared to the HIV-
negative women. This was consistent with the 
findings of similar studies in Kisumu, Kenya (27), 
Harare, Zimbabwe (28), Blantyre, Malawi (22,29), 
and Bobo-Dioulasso, Burkina Faso (31). The under-
lying mechanisms by which HIV infection pro-
duces anaemia are not fully understood. However, 
the suggested mechanisms include a direct effect of 
the virus itself (32), bone marrow suppression as a 
result of cytokine release (33), anaemia as a result 
of chronic inflammation or opportunistic infec-
tion (34), reduced erythropoietin production and 
response (35), and deficiency of vitamin B12 or fo-
lates (29). The implication of these findings is that 
infection with HIV should be considered a possible 
additional aetiologic factor having a significant ef-
fect on haemoglobin levels among pregnant wom-
en even in the absence of evidence of concurrent 
opportunistic infection and/or nutritional deficien-
cy. An earlier report suggested that, in areas with a 
high prevalence of HIV positivity, studies pertain-
ing to anaemia and its aetiology should, therefore, 
include an assessment of HIV status (29).
It  is  pertinent  to  note  that  the  apparently  high 
rate of anaemia recorded among the HIV-negative 
women (76.1%) in this study clearly showed that 
HIV infection was not the only major determinant 
of anaemia observed among the subjects. In many 
areas of sub-Saharan Africa, including Nigeria, ma-
laria and iron deficiency have been shown to sub-
stantially produce anaemia in pregnancy (3,7,11). 
In a review of studies of Plasmodium falciparum-re-
lated anaemia in pregnant women, it was suggested 
that up to 400,000 pregnant women develop mod-
erate or severe anaemia (Hb <8.0 g/dL or haemato-
crit <25%) each year in sub-Saharan Africa as a re-
sult of malaria infection (30). Thus, in populations 
with a high risk of exposure to infectious diseases, 
particularly malaria, the vicious cycle of infection, 
impaired immunity, and anaemia may result in a 
stronger association between HIV infection and 
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anaemia at earlier stages of the disease (14). Iron 
deficiency has been described as the most common 
cause of anaemia relating to nutrition (1). Other 
nutritional deficiencies (vitamin B12, folic acid, and 
vitamin A), congenital blood disease, alpha-thala-
ssaemia,  and  glucose-6-phosphate  deficiency) 
and some infections (hookworm, schistosomia-
sis, or tuberculosis) may contribute to anaemia in 
pregnancy (3,4,6,7). Iron-deficiency anaemia has, 
however, assumed a major maternal health prob-
lem in the subregion mainly because many people 
cannot afford foods rich in haem iron, and other 
dietary factors or cooking methods may inhibit 
absorption of iron (6). This may have had a con-
siderable contribution to anaemia observed in this 
study. Although it was reported that the dietary 
intake of iron by people living in developing coun-
tries is generally high (36), iron deficiency remains 
prevalent in most developing countries, including 
Nigeria (37). This apparent paradox is because the 
iron being consumed is predominantly in the non-
haem form, which is poorly absorbed, and some of 
this non-haem iron is from contamination of food 
with iron from soil, dust, and water; iron leaching 
into food during storage and cooking; contamina-
tion during food processing, such as milling; and 
the practice of geophagy (14,36).
Furthermore, we observed from our study that most 
pregnant women did not commence the intake of 
chemoprophylactic drugs, including haematinics 
and folate, until they commenced to attend an-
tenatal care clinics. It was, therefore, not surprising 
that the majority of the participants in this study 
was anaemic as they were on their first visit to 
antenatal care clinics since the commencement of 
their present pregnancy and had not started tak-
ing routine pregnancy drugs. Reports from vari-
ous parts of sub-Saharan Africa have consistently 
indicated that women attending the antenatal care 
clinic have a high prevalence of anaemia (6,7). The 
findings of this study, therefore, suggest that ante-
natal measures that can successfully target this 
problem are of critical importance. Measures, such 
as routine chemoprophylaxis which is usually ad-
ministered during visit to antenatal care clinic as 
pregnancy progresses, have been found to be useful 
in reducing anaemia (4).
When gestational age was related to anaemia, in-
terestingly, women in their second pregnancy 
trimester were significantly more anaemic than 
their counterparts in their first and third trimesters 
(p<0.05). The reason for this outcome was not ap-
parently clear. However, anaemia in many areas of 
Africa was described as usually most severe in the 
second trimester of gestation, especially following 
a period of acute infection, e.g. malaria, in the first 
trimester (11,13).
Our inability to assess other possible factors that 
may contribute to anaemia during pregnancy in 
the present study population was a major draw-
back to this investigation. The lack of any iron in-
dicator, i.e. ferritin or serum transferrin receptor, is 
a major limitation of this study. Another limitation 
of this study was the lack of information on the 
disease stage of HIV-infected women. These limita-
tions may have affected the adequate assessment 
of the contributory role of HIV infection on anae-
mia observed among the subjects. Future research 
incorporating  these  aspects  is  advocated.  This  is 
because despite multiple aetiologies of anaemia in 
pregnancy, they are all preventable. Therefore, the 
knowledge of the relative importance of the differ-
ent causes of anaemia in pregnancy should form 
the basis for intervention strategies to control anae-
mia (3).
Since maternal and child-health services are the 
most accessible health services in many commu-
nities of the developing world, antenatal care ser-
vices in particular could serve as the pivotal entry 
point  for  simultaneous  delivery  of  interventions 
for the prevention and control of anaemia and HIV 
infection in pregnant women and their neonates 
with linkages to the community, child health, HIV 
counselling and testing, treatment, care and sup-
port services, family planning, and other services 
(2,8,28,29). The transmission of HIV by blood 
transfusion makes it more urgent to prevent anae-
mia and avoid the need for blood transfusions. 
Therefore, public-health policies aimed at increas-
ing haemoglobin levels should continue to support 
programmes  that  provide  iron  supplementation. 
Screening and treatment for anaemia should be 
included in HIV care initiatives, particularly those 
that target women (14). The public-health signifi-
cance of this cannot be overstated as the resolution 
of HIV-related anaemia has been shown to improve 
the quality of life, physical functioning, energy, 
and fatigue in individuals with HIV infection (38). 
If coherence is ensured at each level of the mater-
nal healthcare-delivery system in sub-Saharan 
Africa, factors associated with anaemia which, of 
course, are largely preventable, and the effects of 
anaemia on maternal health and pregnancy out-
comes among HIV-infected and uninfected women 
could be minimized with the use of cost-effective 
and technologically-feasible public-health inter-
ventions.Uneke C.J et al. HIV infection and anaemia in pregnancy
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